Cargando…
Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening
Oral delivery is the most common mode of systemic drug application. Inhalation is mainly used for local therapy of lung diseases but may also be a promising route for systemic delivery of drugs that have poor oral bioavailability. The thin alveolar barrier enables fast and efficient uptake of many m...
Autor principal: | Fröhlich, Eleonore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241192/ https://www.ncbi.nlm.nih.gov/pubmed/28574335 http://dx.doi.org/10.1080/10717544.2017.1333172 |
Ejemplares similares
-
Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
por: Fröhlich, Eleonore
Publicado: (2019) -
Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
por: Mehta, Piyush Pradeep, et al.
Publicado: (2023) -
Alveolar proteinosis due to toxic inhalation at workplace
por: Santos, Gabriela F., et al.
Publicado: (2020) -
Screening for Effects of Inhaled Nanoparticles in Cell Culture Models for Prolonged Exposure
por: Meindl, Claudia, et al.
Publicado: (2021) -
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
por: Fröhlich, Eleonore
Publicado: (2021)